All Episodes

A bitter pill to swallow: young people dislike tablets more than old

Kemwell CEO says environmental efforts are worth the cost

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

Is risk-based clinical trial monitoring too flexible for the regulators?

Optimism is returning to the pharma fine chemicals sector, says analyst

Cobra Biologics talks recent fill finish acquisition and future growth plans

Catalent says sharing with industry will not dull competetive edge

Capsugel expands liquid fill capsule capabilities

Bend Research hunting new partnerships to boost bioavailability offering

Changes to EU clinical trial laws will mean fairer playing field, says Clinipace

New filtration tech boosts biomanufacturing yields, says Sartorius

Submit good REMS proposals for FDA brownie points, says RAPS author

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Initial investment in REMS means big pay-put for pharma, says RAPS author

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

R&D and commercial work together to design trials, says DIA

Fette's 'common sense' approach to boosting production

Single-use is the future of biomanufacturing: report from Interphex

SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Catalent eyes emerging market expansion of end-to-end development service model

Pharma needs to rethink supply chains in an era of patent expiry and global outsourcing

Aptar Pharma says new eDevices will speed up regulatory approval

An experienced CMO is key to successful biologics development says Cobra Biologics

Excipact scheme to launch next week

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Cargill stresses importance of cost- efficient taste masking in drug manufacturing

The future of HPAPIs according to industry insiders

Embedded service providers are future of the industry, says RPS

Endeavour creates new intermediates for prion drug developers

Almac sees growing demand for non-GMP contracting

The right questions key to assessing CRO performance, says study team

BASF talks excipients, raw materials and development plans at CPhI 2011

CROs' complex demands are changing the tissue supply biz, says industry expert

Pharma sponsors want better quality CRO performance data, says CRO Analytics

Patient Recruitment Outsourcing in emerging markets: the good, the bad, and the ugly

Patient recruitment must evolve, says Cutting Edge Information

Patient recruitment best outsourced, says market analyst

Realistic, evidence-based patient recruitment goals are key, Shire

INC Research CEO reflects on Kendle acquisition

Firecrest's site performance software goes mobile

Excipact auditing certification scheme explained

Parexel CEO reflects on Pfizer deal

Two-stage development model needed to cut attrition rates, says expert

Continuous manufacturing offers QbD and PAT advantages says ISP

LB Bohle sees increasing demand for ‘try before you buy’ demos

ATMI unveils helium integrity testing for bioprocess vessels at Interphex 2011

UNCTAD to discuss fostering drug manufacturing in Africa

Social media boosting patient recruitment, but FDA guidance needed

Biopharm waste material mix a chance to cut landfill costs

Contract packagers must adapt to surge in serialisation

Clariant launches Pharma packaging colour unit

Big pharma more open to strong relationships, less heavy handed

ISP discusses solvent selection and solids in spray drying

‘Guinea piggers’ at large in the pharmaceutical industry

Almac invests in biocatalysis lauding cost and environmental benefits

Global reach key for CDMOs, says Recipharm CEO

BioClinica bites back at Nicusa Capital's call for leadership changes

Regulatory expert insight: electronic submission

REMS a cross departmental challenge for drugmakers says PPD

Biopharma needs value focused commercial model, says Quintiles

eClinical talks future of data management

NQR for counterfeit detection on factory floor and at pharmacy

Patient recruiters & regulators educating each other as trials globalise

Regulatory expert insight: Regulatory information management

KCAS talks biomarker strategy development

Almac Diagnostics discusses new biomarker service

Asia Pacific trial sector poised for continued growth, says Novotech

USP proposals on trace elements a boost for ICP, says Thermo Fisher Scientific

Regulatory expert insight: Business Processing Outsourcing

ERT develops IVR suicidality monitoring for trials

Demand for discovery services recovering, says Domainex

Biomarkers “indispensible” in cancer drug development, says Quintiles

Data, patients and payers key to “New Health” success, says Quintiles

Industry has key role to play in COE anti-counterfeiting treaty

Safety and value driving Phase IV growth at CROs; EVP

Potential for trials in Russia "enormous", says ClinStar

US presence is a must for biologics producers, says Recipharm

Liquent and Take Solutions team on regulatory submissions

Atacama CEO on Excella deal and development of PDG for HPAPIs

INC forms ePRO partnership with invivodata

Centralising ECG trial data can cut costs 40%, says ERT

Quintiles opens Nairobi office

Adaptive approach to trial design and operation is key, Health Decisions

Payne buys BP Labels secure pharma packaging biz

SAFC preparing for inevitable shift to cell culture vaccines

Informex – companies hope for a brighter 2010

SAFC building big pharma relationships to drive growth

MDS' sites "perfectly dovetail" with Ricerca's capacity; VP

Trial sponsors and CROs must do more to recruit older people, says EU group

MENA emerging as trial destination says ClinTec CEO

Adaptive methods can improve personalised medicine trials; CEO

14 C "synth to clinic" simplifies development process, says Quotient CEO

AAPS - trends in turbulent times

AAPS - round up of day one

CPhI 2009 - Road to recovery?

CPhI 2009 show preview

Transcrip offers experts to augment in-house drug development

TFS and Siemens hope to have process analysis down PAT

Symyx launches CDMO

Quotient Bioresearch buys Edinburgh facility and sets up new clinical unit

Cisiv launches Baseline Plus for "real world" trials

First USP OK for rHAs a "significant advantage", says Novozymes

Time of rapid change in fine chemicals supply, says SAFC

Packaging feeling effects of downturn, says Alcan pharmaceutical packaging president

"Fundamentals for contract research remain strong," says F&S' Barath Shankar

Nanotech polymer manufacture may help create better packaging

Deuteration may help drug development

Novartis comments on $490m cell-culture vaccine contract

Interview with IPEC China chairman Nevin Cheng

Light microscopy technique for improving contaminant analysis

Icon boosts bioanalytical presence through Prevalere buy

AAPS preview

Latest podcast